EzySpot

Similar stories

Japan IVD Market By Diagnostics 1 year 21 weeks ago

According to Renub Research Japan In Vitro Diagnostics market is expected to surpass US$ 4.3 Billion by the end of year 2024. Renub Research report titled “Japan In Vitro Diagnostics (IVD) Market, By Diagnostics (Urine & Feces, Hematology, Clinical Chemistry, Self Monitoring of Blood Glucose (SMBG), Tumor Marker, Immunology, Infectious disease, Microbiology, Pathology and Genetic Testing) Companies (Roche Diagnostics, Sysmex Corporation, Abbott Laboratories & Others), Reimbursements, Porter's Model, Growth Drivers, Challenges, Opportunities” provides Japan In Vitro Diagnostics (IVD) Market.

China In-Vitro Diagnostics Market is expected to grow with 19% CAGR by 2022 2 years 30 weeks ago

In Vitro Diagnostics (IVDs) are medical devices and accessories that are used to perform tests on the specimens taken from the human body such as blood, urine and tissue in order to treat, mitigate, monitor drug therapies, cure, or prevent illness or its abnormality.

Japan In Vitro Diagnostics (IVD) Market Outlook to 2024 1 year 20 weeks ago

Japan In Vitro Diagnostics Market, By Diagnostics (Urine & Feces, Hematology, Clinical Chemistry, Self Monitoring of Blood Glucose (SMBG), Tumor Marker, Immunology, Infectious disease, Microbiology, Pathology and Genetic Testing) Companies (Roche Diagnostics, Biomerieux, Abbott Laboratories & Danaher Corporation), Reimbursements, Porter's Model, Growth Drivers, Challenges, Opportunities

In Japan In vitro Diagnostic comes under medical device, which is consumable or disposable and used to collect numerous bio-samples under various medical conditions. Japan In vitro Diagnostics market is expected to surpass US$ 4.3 Billion by the end of year 2024.

China IVD Market Opportunities 1 year 26 weeks ago

China In–Vitro Diagnostics (IVD) Market is projected to exceed US$ 12 Billion by the end of year 2024. Renub Research report titled “China In–Vitro Diagnostics (IVD) Market, By Diagnostics [Clinical Chemistry, Immunoassay, Hematology, Coagulation, Microbiology, Molecular Testing, Self Monitoring of Blood Glucose (SMBG), Point of Care Testing (POCT)], Companies (Roche Diagnostics, Sysmex Corporation, Mindray Medical International Limited, Shanghai Kehua Bio-Engineering Co. Ltd., Abbott Laboratories & Others)” provides a complete analysis of China In–Vitro Diagnostics (IVD) Market.

Global Molecular Diagnostics Market Size, Industry Study & Forecast Report 2017 2 years 21 weeks ago

Bharat Book Bureau Provides the Trending Market Research Report; on "Molecular Diagnostics Market Global Briefing 2017", Global Molecular Diagnostics Market Briefing 2017 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global molecular diagnostics market.

Global In Vitro Diagnostics Technologies Market Research Report 2017-2022 1 year 51 weeks ago

The report provides information on industry overview, market size, latest developments, industry trends, Key players, global presence, and their future prospects.

The Global In Vitro Diagnostics Technologies Market should reach $102.4 billion by 2022 from $74.1 billion in 2017 at a compound annual growth rate (CAGR) of 6.7%, from 2017 to 2022.

China In-vitro diagnostics market is expected to be triple its market size by the end of 2022 2 years 39 weeks ago

China In-vitro diagnostics market is expected to be triple its market size by the end of 2022 from its market size in 2016. China In-Vitro Diagnostics sector is expected to grow with a double digit CAGR of 19.01% in future. With such a huge growth rate China is poised to become the world’s largest In–vitro Diagnostics (IVD) Market in the next few years for both domestic and foreign IVD products. The In–Vitro Diagnostics (IVD) Market in China has been growing rapidly over the past few years and is expected to grow steadily in the coming future, with major growth potential in segments such as contagious disease testing, chronic disease testing and diagnosis in early stages of disease.